These immunophenotypic markers help differentiate it from other aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), which often shows a lower Ki-67 index and variable expression of BCL6 and BCL2. This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.